Bristol’s Amylin Deal Heralds Acquisition Hunger
Bristol-Myers Squibb Co.’s $5.3 billion deal to buy diabetes drugmaker Amylin Pharmaceuticals Inc. (AMLN) gives Bristol (BMY) immediate access to a market of growing medical need, while heralding a...
View ArticleAntipsychotic drugs tied to diabetes in pregnancy
(Reuters Health) – Women who take antipsychotic medications while pregnant may have an increased risk of developing diabetes, according to a new Swedish study. Researchers found that out of 360,000...
View ArticleFDA Approves Lucentis® (Ranibizumab Injection) for Treatment of Diabetic...
– First Major Treatment Advance in More Than 25 Years for Sight-Threatening Condition – South San Francisco, Calif. — August 10, 2012 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX:...
View ArticleCaution: New Study Alleging HFCS-Diabetes Link is Flawed and Misleading, Says...
WASHINGTON, Nov. 26, 2012 — Authors Target HFCS, while Ignoring it is Nutritionally Equivalent to Sugar WASHINGTON, Nov. 26, 2012 /PRNewswire-USNewswire/ — A new study, to be released Tuesday, November...
View ArticleMerck, Bristol Diabetes Drugs Linked to Pancreatitis Risk
Diabetes drugs sold by Merck & Co. (MRK) and Bristol-Myers Squibb Co. (BMY) may double a user’s risk of developing an inflammation of the pancreas linked to cancer and kidney failure, an analysis...
View ArticleAn Uproar Over a Diabetes Article, With a Back Story
Many Times readers, some of whom have Type 1 diabetes, are upset over an article last Sunday in which Elisabeth Rosenthal explored the often extraordinary expense of treating the disease. It was an...
View ArticleHuman gut cells turned into insulin producers may treat diabetes
Scientists have converted human gut cells into insulin producers by turning off a single gene in an experiment that suggests a novel way forward in treating diabetes. Using a miniature model of the...
View ArticleClik here to view.
The Tour de Cure event hosted by the American Diabetes Association of...
CUYAHOGA FALLS — The Tour de Cure event hosted by the American Diabetes Association of Northeast Ohio has already raised $250,000 for diabetes research in the region, according to Melissa Sutton, the...
View ArticleClik here to view.
New effort to fight diabetes in Sonoma County
Sonoma County medical providers are taking aggressive steps to deal with the high rate of patients with diabetes admitted to local hospitals, a trend that is said to be driving up hospital costs. In...
View ArticleClik here to view.
Inhalable insulin for diabetes wins FDA approval
The Food and Drug Administration on Friday approved a long-delayed inhalable diabetes medication to help patients control their blood sugar levels during meals. The FDA cleared MannKind Corp.’s drug...
View Article
